<DOC>
	<DOCNO>NCT01356901</DOCNO>
	<brief_summary>The purpose observational study measure real-life persistence , adherence clinical effectiveness entecavir patient chronic Hepatitis B viral infection .</brief_summary>
	<brief_title>Persistence , Adherence Clinical Effectiveness Entecavir Chronic Hepatitis B Patients</brief_title>
	<detailed_description>Sampling Method : Probability Sample ( consecutive patient sampling )</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Male female treatment na√Øve pretreated CHB patient least 18 year age Written inform consent All relevant condition accord Summary product characteristic ( SmPC ) Human immunodeficiency virus ( HIV ) , Hepatitis C virus ( HCV ) Hepatitis D virus ( HDV ) coinfection Patients currently include investigational trial CHB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>